TCT 2019 | PARTNER 3: Obvious Short-Term Quality of Life Improvement, but What Happens Afterwards?

Courtesy of SBHCI.

Patients with severe aortic stenosis and low surgical risk showed decreased mortality, stroke, and heart failure hospitalization at one year with transcatheter aortic valve replacement compared with surgery. Improved quality of life may seem an obvious consequence, but until now that was mere speculation.

Highlights TCT 2019

This work, presented at the TCT 2019 Scientific Sessions and simultaneously published in JACC, analyzes precisely that: short- and long-term quality of life of patients who underwent transcatheter aortic valve replacement vs. surgery.

This analysis included 1000 low-risk patients with severe aortic stenosis who were randomized to balloon-expandable valve vs. surgery between 2016 and 2017.


Read also: TCT 2019 | EURO-CTO: Results at 3 Years of CTO Recanalization vs. Optimal Medical Treatment.


Quality of life was measured at baseline, 1, 6, and 12 months by means of the Kansas City Cardiomyopathy Questionnaire (KCCQ), SF-36, and EQ-5D.

At one month from the procedure, results showed that patients who underwent transcatheter aortic valve replacement had much better scores than patients who underwent surgery (p < 0.0001).

At 6 and 12 months, such difference remained in favor of the balloon-expandable valve, but the curves were closer, narrowing the gap (p < 0.04).

The ratio of patients with excellent results was higher with TAVR, both at 6 months (90.3% vs. 85.3%; p = 0.03) and at 12 months (87.3% vs. 82.8%; p = 0.07).

Conclusion

Patients with severe aortic stenosis and low surgical risk who undergo transcatheter aortic valve replacement with a balloon-expandable valve have better quality of life scores, both in the short and in the long term, compared with surgery.

Courtesy of SBHCI.

Link to the SBHCI publication HERE

partner3-tct2019

Original Title: PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk.

Author of the Original Article: Suzanne J. Baron.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....